Influenza A virus vaccine H5N1 (Emergent BioSolutions)

N/A

Report date: 2024/04/22 20:00:10

Base Information

Drug NameInfluenza A virus vaccine H5N1 (Emergent BioSolutions)
Drug Alias NamePXVX-0103Ad4-H5-Vtn
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza in BirdsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmergent Biosolutions IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsInfluenza in BirdsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A